Edition:
United Kingdom

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

1.66USD
18 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.66
Open
$1.79
Day's High
$1.79
Day's Low
$1.61
Volume
82,390
Avg. Vol
75,570
52-wk High
$6.94
52-wk Low
$1.61

Chart for

About

Nabriva Therapeutics plc is a clinical stage biopharmaceutical company. The Company is engaged in engaged in the research and development of novel anti-infectives to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The Company’s medicinal chemistry has enabled targeted discovery of novel... (more)

Overall

Beta: --
Market Cap(Mil.): $304.02
Shares Outstanding(Mil.): 36.63
Dividend: --
Yield (%): --

Financials

  NBRV.OQ Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -24.70 -- --
ROI: -87.80 9.00 14.96
ROE: -88.10 10.14 16.53

Earnings vs. Estimates